Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Lymphedema
Interventions
DRUG

Indocyanine Green (ICG)

"Near-infrared Fluorescence Lymphatic Imaging (NIRFLI) using Indocyanine Green (ICG) is used to visualize lymphatic vessel anatomy and function."

DEVICE

Near-infrared Fluorescence Lymphatic Imaging (NIRFLI)

"Near-infrared Fluorescence Lymphatic Imaging (NIRFLI) using Indocyanine Green (ICG) is used to visualize lymphatic vessel anatomy and function."

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

The University of Texas Health Science Center, Houston

OTHER

NCT02949726 - Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development | Biotech Hunter | Biotech Hunter